Table 2.
All data | Excluding ALS within 5 years | |||||||||
n | Cases | HR (95% CI) | P value | Adjusted p value | n | Cases | HR (95% CI) | P value | Adjusted p value | |
Total cholesterol | 469 500 | 326 | 1.00 (0.90 to 1.12) | 0.960 | 0.960 | 469 354 | 180 | 1.07 (0.93 to 1.24) | 0.361 | 0.512 |
Total cholesterol:HDL ratio | 429 710 | 294 | 1.17 (1.05 to 1.31) | 0.006 | 0.031 | 429 578 | 162 | 1.19 (1.03 to 1.39) | 0.022 | 0.123 |
LDL cholesterol | 468 618 | 325 | 1.01 (0.91 to 1.12) | 0.854 | 0.960 | 468 472 | 179 | 1.11 (0.96 to 1.28) | 0.154 | 0.356 |
HDL cholesterol | 429 789 | 294 | 0.84 (0.73 to 0.96) | 0.010 | 0.035 | 429 657 | 162 | 0.81 (0.67 to 0.97) | 0.022 | 0.123 |
Triglycerides | 469 126 | 326 | 1.08 (0.97 to 1.20) | 0.148 | 0.325 | 468 980 | 180 | 1.04 (0.90 to 1.20) | 0.617 | 0.754 |
Apolipoprotein A1 | 427 427 | 291 | 0.83 (0.72 to 0.94) | 0.005 | 0.031 | 427 297 | 161 | 0.83 (0.70 to 0.99) | 0.043 | 0.157 |
Apolipoprotein B | 467 121 | 324 | 1.01 (0.90 to 1.12) | 0.916 | 0.960 | 466 976 | 179 | 1.11 (0.96 to 1.28) | 0.162 | 0.356 |
HbA1c | 466 412 | 323 | 0.98 (0.88 to 1.10) | 0.770 | 0.960 | 466 267 | 178 | 0.93 (0.78 to 1.10) | 0.373 | 0.512 |
Excess MET | 402 300 | 275 | 0.93 (0.82 to 1.05) | 0.259 | 0.475 | 402 179 | 154 | 0.99 (0.84 to 1.16) | 0.882 | 0.882 |
BMI | 499 314 | 336 | 1.04 (0.82 to 1.17) | 0.444 | 0.698 | 499 166 | 188 | 1.08 (0.93 to 1.25) | 0.302 | 0.512 |
Creatinine | 469 268 | 326 | 0.86 (0.74 to 1.02) | 0.076 | 0.210 | 469 122 | 180 | 0.96 (0.79 to 1.17) | 0.696 | 0.765 |
Hazard ratios indicated for a 1 SD increase in variable level.
ALS, amyotrophic lateral sclerosis; BMI, body mass index; HbA1c, glycated haemoglobin A1c; HDL, high density lipoprotein; HR, hazard ratio; LDL, low density lipoprotein; MET, metabolic equivalent task.